AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicrite OD 30mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Eswar Therapeutics Pvt Ltd

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Glicrite OD 30mg/500mg Tablet ER

Glicrite OD 30mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medicine complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle adjustments are vital for effective diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counteract hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate low blood sugar. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glicrite OD 30mg/500mg Tablet ER

Adult-onset diabetes

Major Benefits of Glicrite OD 30mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Glicrite OD 30mg/500mg Extended-Release tablets with a meal.

Common Side effects of Glicrite OD 30mg/500mg Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glicrite OD 30mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Glicrite OD 30mg/500mg Extended-Release Tablets with food.

How Glicrite OD 30mg/500mg Tablet ER works:

Extended-release Gliclazide/Metformin tablets (Glicrite OD, 30mg/500mg) contain a dual anti-diabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glicrite OD 30mg/500mg extended-release tablets is contraindicated due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glicrite OD tablets (30mg/500mg) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential advantages outweigh the known hazards. Always seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glicrite OD 30mg/500mg tablets are likely not suitable for use while breastfeeding. Available human data indicate potential transfer of the medication to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glicrite OD 30mg/500mg Extended-Release tablets, as dose modification may be necessary. Consult your physician for guidance. For individuals with severe kidney disease, Glicrite OD 30mg/500mg Extended-Release tablets are contraindicated. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glicrite OD 30mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a reduced Glicrite OD 30mg/500mg Extended-Release tablet dose; however, its use is contraindicated in those with severe liver disease. Medical advice is recommended.

What if you forget to take Glicrite OD 30mg/500mg Tablet ER :

Should you forget a dose of Glicrite OD 30mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glicrite OD 30mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glicrite OD 30mg/500mg Tablet ER

Glicrite OD 30mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glicrite OD 30mg/500mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glicrite OD 30mg/500mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glicrite OD 30mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glicrite OD 30mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Glicrite OD 30mg/500mg ER tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glicrite OD 30mg/500mg ER tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glicrite OD 30mg/500mg ER tablets with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glicrite OD 30mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for treating type 1 diabetes.
Glicrite OD 30mg/500mg ER tablets can cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, may also occur. Prolonged use may result in vitamin B12 deficiency.
Glicrite OD 30mg/500mg ER tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glicrite OD 30mg/500mg Tablet ER can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect is avoidable by excluding patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Glicrite OD 30mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Glicrite OD 30mg/500mg ER tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glicrite OD 30mg/500mg Tablet ER is contraindicated in patients with known allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining alcohol with Glicrite OD 30mg/500mg ER tablets is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glicrite OD 30mg/500mg Ta...
76
MRP 93
18% off